November 3rd, 2026Complement inhibition in GA: Timing, safety, and follow-upMurtaza K. Adam, MD, reviews 3 patient cases to explore referral patterns, neovascularization after treatment, and barriers to care.Read more
November 2nd, 2026NeuroOp Guru: Flow-diverting stents and vision — safe or risky?Andrew G. Lee, MD, and Drew Carey, MD, break down the visual safety of flow-diverting stents for carotid-ophthalmic aneurysms.Read more
November 17th, 2026The important role of midface support in undereye rejuvenation A structure-first approach to blepharoplasty and filler yields more durable, natural results.Read more
November 17th, 2026Q&A: Caroline R. Baumal, MD, from academic retina to the C-suite and back | Eichenbaum Acorns Industry leadership gave her a wider lens that she now brings to patient care.Read more
November 13th, 2026Longer anti-VEGF intervals in AMD, BRVO, and DME: 3 clinical casesRetinal thickness fell by more than 100 µm within 8 weeks in each caseRead more
November 13th, 2026Geographic atrophy: Treatment decisions before foveal involvementTwo cases highlight when to start therapy in extensive and early atrophyRead more
November 12th, 2026Anti-VEGF switches for persistent fluid: A review of 3 clinical casesFluid decreased in vein occlusion, AMD, and DME on aflibercept 8 mg or faricimab.Read more
November 11th, 2026The One Thing: GA’s last frontier, the toll of ongoing care, back to glucose basics | Episode 6R. Ross Lakhanpal, MD, FACS, Anu Patel, MD, and Yasha S. Modi, MD, MHS, point to cell replacement in geographic atrophy, care burden, and glycemic control.Read more